Walmart-owned e-retail company Flipkart may soon make another important deal in the e-pharma sector. Flipkart is in talks to buy a stake in startup Pharmallama run by Mera Dawai Pvt Ltd. According to a report in Live Mint, Flipkart may acquire the entire platform along with buying the technologies of the Bengaluru-based pharma startup.
not yet officially confirmed
In the report of Live Mint, this information has been given by quoting two sources related to the case. However, till now nothing has been said officially about this news from Flipkart or Pharmallama. Any other information related to this deal (Flipkart Pharmallama Deal) like how much this deal is going to happen etc. has not been revealed yet.
Flipkart’s second deal in e-Pharma
If this news turns out to be true, then this will be Flipkart’s second deal in the e-pharma sector. With this, Flipkart’s position in the e-Pharma sector will become stronger than before and it will compete with companies like Tata 1mg, Pharmeasy, Reliance’s Netmeds, Apollo Pharmacy and Amazon. E-pharma companies will get direct competition.
Started in the year 2020
Online medicine delivery startup Pharmallama was started in June 2020 by Achintya Dayal, Arjun Raghunandan and Dipesh Rajpal. Dayal and Raghunandan also run a travel tech startup called Kiplist, while Rajpal has previously been one of the founders of two health-tech platforms Med365 and LifCare.
This presence of Flipkart already
Flipkart entered the e-pharma sector in the year 2021. It then acquired the majority stake in Sasta Sundar Marketplace Limited, the company that operates Sasta Sundar.com. The deal was done in November 2021 through Flipkart Health Private Limited, a subsidiary of Flipkart. Flipkart also invested in diabetes management platform Beat0 (BeatO) last year through the venture capital arm Flipkart Ventures.






